The necessity of having a proper dose of (-)deprenyl (D) to prolong the life spans of rats explains discrepancies among different studies in the past

Annals of the New York Academy of Sciences

Volumn 1067, Issue 1, 2006, Pages 375-382

  Kitani, Kenichi ^a   Kanai, Setsuko ^b   Miyasaka, Kyoko ^b   Carrillo, Maria Cristina ^c   Ivy, Gwen O ^d  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

( )deprenyl; Antioxidant enzymes; F344 DuCrj male and female rats; Optimal dose range; Specific pathogen free rats; Survival prolongation

Indexed keywords

ANTIOXIDANT; CATALASE; SELEGILINE; SUPEROXIDE DISMUTASE;

AGE; AGING; ANIMAL EXPERIMENT; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; HORMESIS; LIFESPAN; LONGEVITY; MALE; MOUSE STRAIN; NONHUMAN; RAT;

ANIMALIA;

EID: 33744471651     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1354.053     Document Type: Conference Paper

References (20)

1. Knoll J. 1988. The striatal dopamine dependency of life span in male rats: longevity study with (-)deprenyl. Mech. Ageing Dev. 46: 237 262.
2. Kitani K. C. Minami K. Isobe, et al. 2002. Why (-)deprenyl prolongs survival of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects. Mech. Ageing Dev. 123: 1087 1100.
3. Kitani K. C. Minami T. Yamamoto, et al. 2002. Pharmacological interventions in aging and age-associated disorders: potential of propargylamines for human use. Ann. N. Y. Acad. Sci. 959: 295 307.
4. Milgram N.W. R.J. Racine P. Nellis, et al. 1990. Maintenance of L-deprenyl prolongs life in aged male rats. Life Sci. 47: 415 420.
5. Kitani K. S. Kanai Y. Sato, et al. 1993. Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats: further evidence. Life Sci. 52: 281 288.
6. Kitani K. S. Kanai K. Miyasaka, et al. 2005. Dose-dependency of life span prolongation of F344/Du Crj rats injected with (-) deprenyl. Biogerontology 6: 1 6.
7. Bickford P.C. C.E. Adams S.J. Boyson, et al. 1997. Long-term treatment of male F344 rats with deprenyl: assessment of effects on longevity, behavior, and brain function. Neurobiol. Aging 18: 309 318.
8. Gallagher I.M. A. Clow & V. Glover. 1998. Long term administration of (-)deprenyl increases mortality in male Wistar rats. J. Neural. Transm. 52 Suppl 315 320.
9. Carrillo M.C. S. Kanai K. Kitani, et al. 2000. A high dose of long term treatment with deprenyl loses its effect on antioxidant enzyme activities as well as on survivals of Fischer-344 rats. Life Sci. 67: 2539 2548.
10. Calabrese E.J. & L.A. Baldwin. 2002. Defining hormesis. Hum. Exp. Toxicol. 21: 91 97.
11. Mahmood I. D.K. Peters & W.D. Mason. 1994. The pharmacokinetic and absolute availability of selegiline in the dog. Biopharm. Drug Dispos. 15: 653 664.
12. Carrillo M.C. K. Kitani S. Kanai, et al. 1996. Long term treatment with (-)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain. Life Sci. 59: 1047 1057.
13. Carrillo M.C. K. Kitani S. Kanai, et al. 1994. The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats. Biochem. Pharmacol. 47: 1333 1338.
14. Kitani K. S. Kanai G.O. Ivy, et al. 1998. Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models. Ann. N. Y. Acad. Sci. 854: 291 306.
15. Gallagher I.M. A. Clow P. Jenner, et al. 1999. Effect of long-term administration of pergolide and (-)deprenyl on age related decline in hole board activity and antioxidant enzymes in rats. Biogenic Amines 15: 379 393.
16. Thyagarajan S. J. Meites & S.K. Auadri. 1995. Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats. Endocrinology 136: 1103 1110.
17. Thyagarajan S. S.Y. Felten & D.L. Felten. 1998. Antitumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors. Cancer Lett. 123: 177 183.
18. Thyagarajan S. & S.K. Quadri. 1999. L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors. Endocrine 10: 225 232.
19. Ikeno Y. L. Cortez C. Lew, et al. 2005. Abstract, 34th Annual Meeting of the American Aging Association. P. 32.
20. Schriner S.E. N.J. Linford G.M. Martin, et al. 2005. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308: 1909 1911.